pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
LEADING · news · pharmadog
← back to LEADING
News mentioning LEADING
653
stories
Jul 27, 26
STAT+: As some medical schools embrace RFK Jr.’s nutrition push, they deftly sidestep MAHA priorities
stat
Jul 27, 26
Denmark’s foundation‑fueled biotech boom redraws the Nordic map
biospace
Jul 27, 26
Argenx acquires Forte for $2.2B to get hands on phase 2-stage vitiligo drug
fiercebiotech
Jul 27, 26
American Regent, Inc. Issues Voluntary Nationwide Recall of One Lot of Papaverine Hydrochloride Injection, USP 60 mg/ 2 mL Due to the Presence of Visible Particulate Matter
fda medwatch
Jul 27, 26
Researchers find similar drug development to reimbursement timelines for major markets
raps
Jul 24, 26
Opinion: I led the FDA’s food safety and nutrition center. Here’s what people are missing about the cyclospora outbreak
stat
Jul 24, 26
Amgen deploys patients to defend troubled Tavneos in FDA hearing request
biospace
Jul 24, 26
Study of Yescarta patients reveals genetic red flags for CAR-T therapy side effects
fiercebiotech
Jul 24, 26
Senate advances MAHA-friendly bill for food warning labels and junk food ad bans
stat
Jul 23, 26
Chutes & Ladders—Biogen R&D vet gets in Formation
fiercebiotech
Jul 23, 26
Lilly, with new data, to seek FDA approval of obesity drug retatrutide
biopharma dive
Jul 23, 26
STAT+: FDA is urged by advocacy group to ban DTC prescription drug ads
stat
Jul 23, 26
STAT+: FDA staff and peptide enthusiasts set to clash at advisory panel
stat
Jul 22, 26
Webinar: From Clinical to Commercial: Talent Strategies for Biopharma Growth
biospace
Jul 22, 26
GSK lung cancer drug gets speedy approval following $10.6B deal
biopharma dive
Jul 22, 26
Former FDA cancer chief Pazdur says the agency should restructure
endpoints
Jul 22, 26
Repligen strikes $1.5B BioLife buyout to bag cell therapy product pharmas rely on
biospace
Jul 22, 26
Novartis scraps mid-stage radiopharma asset as Pluvicto soars
biospace
Jul 22, 26
Biopharma dealmaking in 2026: The recovery gathers speed in Q2
endpoints
Jul 22, 26
Royalty Pharma pens $425M deal for slice of sales on AstraZeneca’s ATTR drug
fiercebiotech
Jul 22, 26
As Maui recovers from devastating fires, a study offers vision for new rural health model
stat
Jul 21, 26
STAT+: Anthropic deepens work with rare disease drugs
stat
Jul 21, 26
Novartis stays 'geography-agnostic' in dealmaking amid flurry of China deals
biospace
Jul 21, 26
Dyne gets early 2027 decision date for Duchenne therapy, analysts expect ‘smooth’ review
biospace
Jul 21, 26
Jupiter enters psychedelics space with $100M deal for PharmAla's MDMA drug
fiercebiotech
Jul 21, 26
Agios says adios to sickle cell program over lackluster phase 2 data
fiercebiotech
Jul 21, 26
Roche taps Foundation Medicine’s chief as new North America Diagnostics lead, creates new commercial role
fiercebiotech
Jul 20, 26
Pain drugmaker Latigo outlines plans to go public
biopharma dive
Jul 20, 26
‘There is always a first’: Why US biotech Axiom will begin its IPO journey in Hong Kong
fiercebiotech
Jul 20, 26
Vertex’s IgA nephropathy drug derisked after Novartis, Vera approvals
biospace
← prev
page 15 of 22
next →
